Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

SELLAS Life Sciences Group Inc. (SLS)

6.14   0.49 (8.67%) 11-12 16:00
Open: 5.8 Pre. Close: 5.65
High: 5.98 Low: 5.8
Volume: 646,219 Market Cap: 28M
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.149 - 6.183 6.183 - 6.215
Low: 5.712 - 5.755 5.755 - 5.796
Close: 6.074 - 6.14 6.14 - 6.201

Technical analysis

as of: 2019-11-12 4:31:26 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 10.08     One year: 12.85
Support: Support1: 4.79    Support2: 3.99
Resistance: Resistance1: 8.63    Resistance2: 11.00
Pivot: 6.80
Moving Average: MA(5): 6.31     MA(20): 6.73
MA(100): 7.07     MA(250): 38.35
MACD: MACD(12,26): -0.01     Signal(9): 0.10
Stochastic oscillator: %K(14,3): 13.38     %D(3): 13.67
RSI: RSI(14): 46.32
52-week: High: 100.50  Low: 4.79  Change(%): -93.6
Average Vol(K): 3-Month: 21367  10-Days: 61775

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SLS has closed above bottom band by 34.6%. Bollinger Bands are 3.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 05 Aug 2019 19:57:22 +0000
Health Care Sector Update for 08/05/2019: SLS,ALLK,HSIC,HRTX

Wed, 31 Jul 2019 18:10:32 +0000
Wednesday's ETF with Unusual Volume: VXF

Sun, 03 Mar 2019 15:00:00 +0000
Validea's Top Five Technology Stocks Based On Peter Lynch - 3/3/2019

Sat, 22 Dec 2018 10:06:23 +0000
Validea Benjamin Graham Strategy Daily Upgrade Report - 12/22/2018

Sat, 08 Dec 2018 10:07:40 +0000
Validea Joel Greenblatt Strategy Daily Upgrade Report - 12/8/2018

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 226.54
Shares Float (M) 226.09
% Held by Insiders 2.04
% Held by Institutions 24.08
Shares Short (K) 2150
Shares Short P. Month (K)

Stock Financials

EPS -1.350
Book Value (p.s.) 0.140
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -40.0
Return on Equity (ttm) -359.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -28.37
Levered Free Cash Flow (M) -14.21

Stock Valuations

P/E -4.55
P/E Growth Ratio 0.09
P/BV 43.86
P/S
P/CF -49.03

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-11-08
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.